Brief: Infinity Pharmaceuticals Says On June 27, Got Letter From Nasdaq Determining To Delist Co’S Common Stock From Nasdaq
30/06/2023 23:07
June 30 (Reuters) - Infinity Pharmaceuticals Inc
INFI.O :
* INFINITY PHARMACEUTICALS- ON JUNE 27, GOT LETTER FROM
NASDAQ
DETERMINING TO DELIST CO’S COMMON STOCK FROM NASDAQ
Source text for Eikon: ID:
Further company coverage: INFI.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX